Fuertes, Melody A.
HRN: 22-59-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/18/2025
01/25/2025
IV
4.5gm
Q8
DM Foot
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes